Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from JD Health International, Inc. ( (HK:6618) ) is now available.
JD Health International, Inc. announced the grant of 834,433 Award Shares to its employees under the Post-IPO Share Award Scheme, representing approximately 0.03% of the total issued shares. The shares will vest over various periods ranging from 0.25 to 4 years, with no performance targets attached. This move aims to incentivize employees and align their interests with the company’s growth, potentially enhancing employee retention and satisfaction.
The most recent analyst rating on (HK:6618) stock is a Buy with a HK$31.00 price target. To see the full list of analyst forecasts on JD Health International, Inc. stock, see the HK:6618 Stock Forecast page.
More about JD Health International, Inc.
JD Health International, Inc. operates in the healthcare industry, primarily focusing on providing online healthcare services and products. The company is known for its digital health platform that offers a wide range of medical services, including telemedicine consultations, online pharmacy, and health management solutions.
Average Trading Volume: 12,220,643
Technical Sentiment Signal: Hold
Current Market Cap: HK$138.6B
For an in-depth examination of 6618 stock, go to TipRanks’ Overview page.